Skip to main content
logo
Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.20
-0.05 (-0.54%)
At close: Oct 27, 2025, 4:00 PM EDT
9.20
0.00 (0.00%)
After-hours: Oct 27, 2025, 7:00 PM EDT

Revenue by Product

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Oral Health
3.31B
Log In
Log In
Log In
Log In
Upgrade
Oral Health Growth
3.93%
Log In
Log In
Log In
Log In
Upgrade
Vitamins, Minerals and Supplement
1.70B
Log In
Log In
Log In
Log In
Upgrade
Vitamins, Minerals and Supplement Growth
-0.54%
Log In
Log In
Log In
Log In
Upgrade
Pain Relief
2.56B
Log In
Log In
Log In
Log In
Upgrade
Pain Relief Growth
-0.12%
Log In
Log In
Log In
Log In
Upgrade
Respiratory Health Revenue (Pre-FY2025 Reporting)
1.68B
Log In
Log In
Log In
Log In
Upgrade
Respiratory Health Revenue (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Digestive Health and Other Revenue (Pre-FY2025 Reporting)
1.98B
Log In
Log In
Log In
Log In
Upgrade
Digestive Health and Other Revenue (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
North America
4.04B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-4.09%
Log In
Log In
Log In
Log In
Upgrade
EMEA & LatAm
4.63B
Log In
Log In
Log In
Log In
Upgrade
EMEA & LatAm Growth
-2.50%
Log In
Log In
Log In
Log In
Upgrade
APAC
2.56B
Log In
Log In
Log In
Log In
Upgrade
APAC Growth
1.79%
Log In
Log In
Log In
Log In
Upgrade

Other

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
North America Adjusted Operating Profit
1.00B
Log In
Log In
Log In
Log In
Upgrade
North America Adjusted Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
EMEA & LatAm Adjusted Operating Profit
1.05B
Log In
Log In
Log In
Log In
Upgrade
EMEA & LatAm Adjusted Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
APAC Adjusted Operating Profit
539.00M
Log In
Log In
Log In
Log In
Upgrade
APAC Adjusted Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Profit
-93.00M
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Organic Revenue Growth
5.00%
Log In
Log In
Log In
Log In
Upgrade
Sales Growth due to Price
3.70%
Log In
Log In
Log In
Log In
Upgrade
Sales Growth due to Volume/Mix
1.30%
Log In
Log In
Log In
Log In
Upgrade